Taiwan FDA registration 1ee49a788267b407142ccfdd78ec6886
Gyn Glaucoma Treatment System
TW: 捷恩青光眼治療系統
Taiwan·Risk Class 2·Trelleborg Sealing Solutions US, Inc.;; Allergan Sales, LLC·Registered Jan 09, 2018 – Jan 09, 2028ActiveRegistration details
- Analysis ID
- 1ee49a788267b407142ccfdd78ec6886
- Customs Code
- DHA05603009600
Company information
- Manufacturer Country
- United States
- Authorized Representative
- ABBVIE BIOPHARMACEUTICALS GMBH TAIWAN BRANCH (SWITZERLAND)
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- M Ophthalmology
- Product Type (Level 2)
- M.3920 Aqueous aqueous veil implants
- Import Information
- Contract manufacturing;; input
Dates and status
- Registration Date
- Jan 09, 2018
- Expiry Date
- Jan 09, 2028
About this record
Access comprehensive regulatory information for Gyn Glaucoma Treatment System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 1ee49a788267b407142ccfdd78ec6886 and manufactured by Trelleborg Sealing Solutions US, Inc.;; Allergan Sales, LLC. The authorized representative in Taiwan is ABBVIE BIOPHARMACEUTICALS GMBH TAIWAN BRANCH (SWITZERLAND).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices